Navigation Links
Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin(R) Sales and Applications Seeking Two Product Approvals in 2009
Date:1/30/2008

and pixantrone. This year we will continue to prepare for submission of a marketing authorization application for XYOTAX and the evaluation of pivotal trial data for pixantrone. Our goal is to ensure that we succeed with Zevalin and are prepared for the future market introductions of XYOTAX and pixantrone."

"On a personal note, while we are adding staff in some areas, it is with great disappointment that we must reduce headcount elsewhere in order to meet these goals," Bianco added.

CTI has begun building a new sales and marketing department to support Zevalin sales. The company will be adding more than 13 positions for Zevalin and other potential drug sales. The Company has also increased staffing in regulatory and manufacturing in preparation for filing for approval of XYOTAX in Europe in March.

About ZEVALIN(R)

Zevalin (Ibritumomab Tiuxetan) is a form of cancer therapy called radioimmunotherapy and is indicated for the treatment of patients with relapsed or refractory low-grade or follicular B-cell NHL, including patients with Rituximab-refractory NHL. It was approved by the FDA in February of 2002 as the first radioimmunotherapeutic agent for the treatment of NHL.

Deaths associated with an infusion reaction symptom complex have occurred within 24 hours of rituximab infusions. Yttrium-90 Zevalin administration results in severe and prolonged cytopenias in most patients. Severe cutaneous and mucocutaneous reactions have been reported. The most serious adverse reactions of the Zevalin therapeutic regimen were primarily hematologic, including neutropenia, thrombocytopenia, and anemia. Infusion-related toxicities were associated with pre-administration of rituximab. The risk of hematologic toxicity correlated with the degree of bone marrow involvement prior to Zevalin therapy. Myelodysplasia or acute myelogenous leukemia was observed in 2 percent of patients (8 to 34 months after treatment). Zevalin should only be used by health car
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics, Inc.
2. Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States
3. Cell Therapeutics, Inc. Announces $6.5 Million Offering
4. Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008
5. Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.s Drug Pipeline
6. InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
7. Cell Therapeutics, Inc. (CTI) Appoints Jim Fong as Vice President, Commercial Operations
8. Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results
9. Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on November 8
10. Cell Therapeutics, Inc. (CTI) CIBC and Rodman & Renshaw Healthcare Conference Presentations to be Webcast
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... release of a new report titled, “Incontinence Devices Markets Worldwide.” ... used to treat and manage urinary incontinence. , ... ... Marketstrat is pleased to announce the release of a new ... addresses world markets for clinical devices used to treat and ...
(Date:12/14/2009)... Young Adults, Attitudes and Behavior Regarding Pregnancy, Contraception, and ... -- Nearly all unmarried young adults ages 18-29 believe ... men and 86% of women) and say that it ... now (86% of men and 88% of women), according ... Prevent Teen and Unplanned Pregnancy. Even so: ,, ...
(Date:12/14/2009)... and HOLLYWOOD, Fla., Dec. 14 ... today a definitive agreement to acquire STARLIMS ... leading provider of laboratory information management systems, ... ,, The acquisition strengthens Abbott,s competitive position ... web-based applications to help laboratories efficiently store, ...
(Date:12/14/2009)... The National Organization for Rare Disorders (NORD) ... to lifetime and annual health insurance caps. In ... newspaper distributed widely on Capitol Hill, NORD said the ... allow caps to continue for most Americans, contrary to ... care reform and welcomes the promises made by President ...
(Date:12/14/2009)... years under government controlled health care, before moving to the U.S. ... and in his new book, Health Reform: The End of the ... system and its threat to real health care! , ... ... diagnostic radiologist from Minnesota, warns Americans not to sell out their ...
Breaking Medicine News(10 mins):Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 2Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 3Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 2Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:NORD Calls for Immediate End to Lifetime Insurance Caps 2Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2
... The Delhi High Court, which is angered by the defence ... from the medical superintendent// about the case where a boy, ... at the hospital in 2001. ,The victim, ... admission to the hospital in July 2000 for treatment of ...
... identified a new strategy to effectively combat the West ... spread through a complex interaction// of nesting birds, mosquitoes ... believed to pave way for viral amplification with mosquito ... the University of Florida have identified how those factors ...
... Patricia Rashbrook, the psychologist and the oldest mother in UK, ... has recently remarried //and undergone fertility treatment. She gave the ... ,She and her husband John Farrant made a joint ... an endeavour undertaken lightly or without courage. A great deal ...
... to chill out. Places such as backyard pool, hot tub and ... cautious and always follow the instructions of their parents. In some ... safety measures such as installing the pool fences and pool alarms. ... install the child proof safety measures as it is small and ...
... researchers at the Aberdeen University it was found that women ... experience unnecessarily high levels of anxiety. About 3,500 women were ... Cervical cancer is on the rise in UK. ... can affect women of any age who were sexually active ...
... blueprint for handling a pandemic, state and local health officials ... of lethal influenza in the U.S. ,While the ... the risk of a pandemic and its transmission, ``the center ... communities,'' the report said. ,A preliminary $7.1 billion ...
Other Medicine News:Health News:A Boy Undergoing Treatment For Cancer Gets AIDS At AIIMS 2Health News:West Nile Virus Can Be Tackled By New Strategy 2Health News:West Nile Virus Can Be Tackled By New Strategy 3Health News:A mother at 63: oldest in UK! 2Health News:Hot Tubs and Spas in the News for Safety Measures 2Health News:Bush Unveils Latest Blueprint for Handling Bird Flu Pandemic 2Health News:Bush Unveils Latest Blueprint for Handling Bird Flu Pandemic 3
(Date:12/14/2009)... SAN FRANCISCO, Dec. 14 Environmental health ... promised announcement about health hazards of bisphenol A ... behavioral changes, reproductive harm and other illnesses, in ... MD, PhD , staff scientist, Natural ... on your doctor for medical advice, FDA must ...
(Date:12/14/2009)... 14 At GeoInvesting.com, we have been tracking ... time now. Our largest hang up had been with ... fiscal June 2010 net income guidance of $11.3 million ... net income of $7.9 million, the increase in shares ... scenario, which depends upon the share price and the ...
(Date:12/14/2009)... N.J., Dec. 14 Authentidate Holding ... provider of secure Health Information Exchange and ... Care of the Carolinas ("HCC"), a home ... a durable medical equipment supplier, have selected ... and standardize processes for the completion of ...
Breaking Medicine Technology:Toxic Chemical bisphenol A Still Not Banned By FDA; Schumer, Gillibrand Call for Ban; Govt Official Warns Public 2GeoInvesting.com Offers Insight Into Two Growing Chinese Pharmaceutical Firms 2Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 2Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 3Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 4Pregnant Women Need Flu Shots 5045 1Pregnant Women Need Flu Shots 5045 2Mindful meditation shared dialogues reduce physician burnout 58212 1Mindful meditation shared dialogues reduce physician burnout 58212 2Mindful meditation shared dialogues reduce physician burnout 58212 3Mindful meditation shared dialogues reduce physician burnout 58212 4Tennessee foresters helping to return chestnuts to American forests 10072 1Tennessee foresters helping to return chestnuts to American forests 10072 2
... 18 The Leukemia & Lymphoma,Society (LLS) and Memgen ... Phase I clinical trial. The trial will use Memgen,s,ISF35, ... Based on its alliance with LLS, Memgen plans ... up to 12 patients who have 17p-, refractory or,resistant ...
... On Wednesday, June 18, 2008,at 8:30 a.m. Eastern/2:30 p.m. ... (Nasdaq: CTIC ; MTA) management team will,host a ... for,access to Phase III Zevalin(R) FIT Trial data., ... 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time ...
Other Medicine Technology:The Leukemia & Lymphoma Society and Memgen Collaborate on CLL Clinical Trial 2The Leukemia & Lymphoma Society and Memgen Collaborate on CLL Clinical Trial 3
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use....
Used when establishing a percutaneous tract for nephrostomy drainage. The guide has a stiff shaft and a gradual transition to a very flexible distal tip. Supplied sterile in peel-open packages. Inten...
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: